cloprostenol and Puerperal-Disorders

The objective of this field trial was to compare the effect of intrauterine (i.u.) antibiotic or intramuscular (i.m.) prostaglandin F2 alpha (PGF2 alpha) on time to pregnancy in dairy cows diagnosed with clinical endometritis between 20 and 33 days in milk (DIM). The case definition of endometritis was the presence of purulent uterine discharge or cervical diameter > 7.5 cm, or the presence of muco-purulent discharge after 26 DIM. There were 316 cows with endometritis from 27 farms assigned randomly within herd to receive 500 mg of cephapirin benzathine intrauterine (i.u.), 500 micrograms of cloprostenol i.m., or no treatment. The rate of resolution of clinical signs 14 d after treatment was 77% and was not affected by treatment. Reproductive performance was monitored for a minimum of 7 mo after treatment. Survival analysis (multivariable proportional hazards regression) was used to measure the effect of treatment on time to pregnancy. There was no benefit of treatment of endometritis before 4 wk postpartum. Administration of PGF2 alpha between 20 and 26 DIM to cows with endometritis that did not have a palpable corpus luteum was associated with a significant reduction in pregnancy rate. Between 27 and 33 DIM, cows with endometritis treated with cephapirin i.u. had a significantly shorter time to pregnancy than untreated cows (hazard ratio = 1.63). In this time period, there was no difference in pregnancy rate between PGF2 alpha and untreated cows, but the difference in pregnancy rate between cows treated with cephapirin i.u. and with PGF2 alpha was not statistically significant. Treatment of postpartum endometritis should be reserved for cases diagnosed after 26 DIM, based on criteria that are associated with subsequent pregnancy rate.

Topics: Animals; Anti-Bacterial Agents; Birth Intervals; Cattle; Cattle Diseases; Cephapirin; Cloprostenol; Endometritis; Female; Lactation; Pregnancy; Puerperal Disorders; Reproduction; Time Factors; Treatment Outcome

The investigations were carried out on a total of 70 cows with puerperal endometritis. In addition to intrauterine antibiotic treatment, 30 experimental animals were administered 20 microg GnRH analogue, buserelin, between days 10 and 12 post-partum followed by 500 microg PGF2alpha analogue, cloprostenol, 10 days later. Forty control cows were treated only with intrauterine antibiotics. Blood samples for progesterone determination were collected from the tail vein twice weekly until day 70 post-partum. The first rise in progesterone level above 3.18 nmol/l occurred significantly earlier in the experimental than in control cows (21.6 +/- 9.2 versus 27.8 +/- 12.3 days; p < or = 0.05). The duration of the first cycle post-partum was 15.0 +/- 4.3 days in experimental and 19.7 +/- 7.3 days in control animals (p < or = 0.05). However, no significant differences were observed in the occurrence of first oestrus post-partum. The involution of the uterus was improved after hormone treatment. At day 42 post-partum, completion of uterine involution was found in 93.3% of hormone-treated cows and in 82.5% of those treated with antibiotic only (p < or = 0.05). Clinical recovery was 96.6% in the experimental and 82.5% in the control group (p < or = 0.05). First service pregnancy rate was significantly better in hormone-treated than control cows (51.7 versus 36.4%; p < or = 0.05). Total pregnancy rate and insemination index values were not significantly improved following GnRH and PGF2alpha treatment. The average service period was 89.8 +/- 21.2 days in cows after hormone treatment, and 112.6 +/- 24.5 days in control cows. The difference was statistically significant (p < or = 0.05). These results indicate, that the sequential GnRH and PGF2alpha application in cows with puerperal endometritis positively affected ovarian function and uterine involution, resulting in improved fertility performance.

Topics: Animals; Buserelin; Cattle; Cattle Diseases; Cloprostenol; Dairying; Dinoprost; Drug Administration Schedule; Drug Therapy, Combination; Endometritis; Erythromycin; Female; Fertility; Fertility Agents, Female; Progesterone; Puerperal Disorders; Tetracycline

Path analysis was used to determine the interrelationships between postpartum administration of gonadotrophin releasing hormone and cloprostenol and the occurrence of reproductive disease and reproductive performance in dairy cows. The data analysed were those collected on 226 Holstein-Friesian cows calving in a commercial dairy herd during a 17 month period (May 1, 1981 to October 1, 1982). Cows administered gonadotrophin releasing hormone at day 15 postpartum experienced an improved rate of uterine involution as determined by rectal palpation nine days later. Although this improved rate of uterine involution reduced the risk of pyometritis, it actually directly delayed conception. Also, gonadotrophin releasing hormone therapy directly resulted in an increased incidence of pyometritis which in turn resulted in an increase incidence of cystic ovarian disease and anestrus. The occurrence of these abnormalities resulted in increased intervals from calving to first observed estrus, first service and conception. In addition to this effect, the administration of gonadotrophin releasing hormone was also associated with increased plasma progesterone concentrations at days 24 and 28 postpartum which delayed conception. Cloprostenol therapy at day 24 postpartum resulted in a decreased plasma progesterone concentration at day 28 postpartum which was directly and indirectly associated with a decrease in the calving to conception interval. The indirect effects were mediated by a reduction in days to first estrus. Cloprostenol therapy also directly resulted in a decreased calving to first observed estrus interval for reasons not attributable to the level of progesterone at day 28.

Topics: Anestrus; Animals; Cattle; Cattle Diseases; Cloprostenol; Endometritis; Estrus; Female; Insemination; Models, Biological; Ovarian Cysts; Pituitary Hormone-Releasing Hormones; Pregnancy; Progesterone; Puerperal Disorders; Reproduction; Suppuration

In a herd of sows 106 sows having 4.3 litters on aver., were over a period of 10 weeks treated on Thursdays with 0.175 mg of cloprostenol on the 111th to 114th day of gestation; 93--95% of the sows treated on the 112th and 113th day farrowed within 33 hours after treatment, 73% after treatment on the 111th day (Table I); the mean period of gestation after treatment was 113.4 +/- 0.9 days. 8 sows that only farrowed 2--5 days after the treatment, had on 21 previous farrowings proved to have significantly longer mean periods of gestation, 115.6 days, than the 112 sows in the control group, having 3.6 litters on average, that farrowed in the same period and section of the piggery as the sows treated with cloprostenol. In total 32 weekend-farrowings occurred in the observation period including 7 farrowings after a period of gestation of 110--113 days, 6 cases of unsuccessfully induced parturition and 19 farrowings on the 114th to 119th day that could have been programmed to occur on Fridays; the number of weekend-farrowings, which for this herd in connection with the weaning procedure normally accounted for about 40--45% of farrowings, could thus be reduced to 7% of farrowings (Table II). Cloprostenol treatment on the 111th day resulting in farrowing on the 112th day leads to a significantly higher rate of piglet mortality after 3 weeks compared with the results after farrowing for control sows that farrowed on the 112th day (Table III); this category of control sows had on previous farrowings proved to have a significantly shorter mean period of gestation, 112.7 days, than that of the sows in the cloprostenol group farrowing on the 112th day which had been 114.3 days on previous farrowings. Farrowing and weaning results after induced parturition resulting in farrowing on the 113th to 115th day showed no significant differences from the results for control sows farrowing spontaneously on the 112th to 115th day of gestation. The incidence of MMA (Table II) was not influenced by the cloprostenol treatment, nor by the number of litters, the length of the period of gestation, or by the piling of farrowings on Fridays.

Topics: Animals; Cloprostenol; Female; Labor, Induced; Lactation Disorders; Mastitis; Metrial Gland; Pregnancy; Prostaglandins F, Synthetic; Puerperal Disorders; Swine; Swine Diseases; Syndrome